Phenotypic and Genotypic Characterisation of Clinical Isolates of Nosocomial Infections
Main Article Content
Authors
I. S. Korotetskiy
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
A. B. Jumagaziyeva
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
S. V. Shilov
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
Т. V. Kuznetsova
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
Z. А. Iskakbayeva
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
A. N. Myrzabayeva
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
N.V. Korotetskaya
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
A. I. Ilin
Scientific Center for Anti-Infectious Drugs,75A al-Farabi Ave., Almaty, 050060, Kazakhstan
O. N. Reva
Centre for Bioinformatics and Computational Biology; Department of Biochemistry, Genetics and Microbiology; University of Pretoria, Pretoria, South Africa
Abstract
The study focuses on identification and characterization of clinical isolates of nosocomial infections with an aim to create a Bank of model microorganisms for further study of mechanisms and prospects of clinical use of novel medicines causing a reversion susceptibility to antibiotics in drug resistant pathogens.
Clinical samples of nosocomial infections were collected from phthisiological hospitals in Almaty. Clinical isolates were characterized by morpho-cultural, tinctorial, physiological and biochemical properties and also by susceptibility to antibiotics. Our studies showed that the isolates are characterized by an increased ability to form biofilms that significantly complicates the therapy and prevention of these outbreaks. Moreover, isolates were characterized by varying degrees of susceptibility to antimicrobial drugs. The strains of Citrobacter were resistant to azithromycin, which is considered as a reserve drug. This fact raises a concern about the circulation and the spread in hospitals of microorganisms resistant to the latest generation of antibiotics.
Obtained genome-scale contigs were used for taxonomic affiliation of the isolates and for identification of genetic determinants of antibiotic resistance. The search for genetic determinants of drug resistance in the obtained genome sequences confirmed the resistance to some antibiotics obtained by phenotypic methods.
Whole genome sequences were obtained for 4 clinical isolates identified as Citrobacter koseri SCAID URN1-2019, Citrobacter freundii SCAID PHRX1-2019, Escherichia coli SCAID URN1-2019 and Streptococcus pneumoniae SCAID PHRX1-2019. The genomes were deposited in the NCBI database under accession numbers CP052059, CP052058, CP052057, and CP052060.
Keywords
nosocomial infection, pathogen, DNA, sequencing, Citrobacter koseri, Citrobacter freundii, Escherichia coli, Streptococcus pneumoniae
Article Details
References
Chen Y., He Y., Zhang W., Huang Y., Fu J., Fu F., Zhou Y. Pathogenic characteristics of nosocomial infections in patients with cerebrovascular diseases and characteristics and treatment of pathogenic bacteria in different seasons // Journal of Infection and Public Health. – 2019. – Vol. 13, No 3. - P. 1-6. 31831394, Crossref.
Edwardson S., Cairns Ch. Nosocomial infections in the ICU // Anaesthesia & Intensive Care Medicine. – 2019. – Vol. 20, No 1. – P. 14-18. Crossref.
Rosenthal V.D., Bat-Erdene I., Gupta D., Belkebir S., Rajhans P., Zand F. et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module // American Journal of Infection Control. – 2020. – Vol. 48, No 4. – P. 423-432. Crossref.
The burden of health care-associated infection worldwide / WHO. – 2016. Available at: URL (accessed 07 May 2020).
Types of healthcare-associated infections. Healthcare-associated infections (HAIs) / CDC. – 2014. Available at: URL infections-hais/hai/ (accessed 04 May 2020).
HAI data and statistics. Healthcare-associated infections / CDC. – 2018. – Available at: URL (accessed 04 May 2020).
Jenkins D.R. Nosocomial infections and infection control // Medicine. – 2017. – Vol. 45, No 10. – P. 629-633. Crossref.
Urinary tract infection (catheter-associated urinary tract infection [CAUTI] and non-catheter associated urinary tract infection [UTI]) and other urinary system infection [USI]) events / CDC. - 2016. – 22 р.
Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Health Care Facility Level / WHO. – 2015. – 59 p.
Khan H., Baig F., Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance // Asian Pacific Journal of Tropical Biomedicine. – 2017. – Vol. 7, No 5. – P. 478-482. Crossref.
High levels of antibiotic resistance found worldwide, new data shows / WHO. - 2018. Available at: URL (accessed 14 May 2020).
Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients // Transpl Infect Dis. – 2017. – Vol. 19,
No 6. – 29 p. Crossref.
ВОЗ публикует список бактерий, для борьбы с которыми срочно требуется создание новых антибиотиков / WHO. - 2018. Available at: URL (accessed 13 May 2020).
Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World // (WHO/CDS/CSR/RMD/2003.6). Available at: URL (accessed 13 May 2020).
Baron E.J., York M., Ferraro M., Rex J., Body B., Forbes B., Poole F., Sahm D., Tenover F., Turnidge J., Wilson M. М35-А2 Abbreviation Identification of Bacteria and Yeasts Approved Guideline-Second Edition / CLSI. – 2008. – 13 p.
Хоулт Дж. Определитель бактерий Берджи. В 2 т. Т.1 – М.: Мир, 1997. – 432 с.
MUK 4.2.2886-11. Идентификация микроорганизмов и определение чувствительности их к антибиотикам с применением автоматизированной системы для биохимического анализа / Государственное санитарно-эпидемиологическое нормирование РФ. – М, 2011. – 41 с.
Performance Standards for Antimicrobial Disc Susceptibility Test // CLSI. - 2010. – Vol. 30, No 1. – 76 р.
Toole G., Kaplan H.B., Kotler R. Biofilm formation as Microbial Development // Annual Review of Microbiology. – 2000. – Vol. 54. – P. 49-79. 11018124, Crossref.
Bankevich A., Nurk S., Antipov D. et al A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing // Journal of Computational Biology. -2012. – Vol. 19, No5. – P. 455-477. doi: 10.1089/cmb.2012.0021.
Okonechnikov K., Golosova O., Fursov M. The UGENE team. Unipro UGENE: a unified bioinformatics toolkit // Bioinformatics. – 2012. – Vol.28, No. 8. – P. 1166-1167.Crossref.
Darling A.C.E., Mau B., Blattner F.R., Perna N.T. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome research. – 2004. –
Vol. 14, No7. – P. 1394-1403. 10.1101/gr.2289704.
Alcock B.P., Raphenya A.R., Lau T. Y. et al. CARD 2020: Antibiotic Resistome Surveillance With the Comprehensive Antibiotic Resistance Database // Nucleic Acids. – 2020. – Vol. 8, No 48. – P. 517-525. Crossref.
Korotetskiy I.S., Jumagaziyeva A.B., Reva O.N., Kuznetsova Т.V., Shvidko S.V., Iskakbayeva Z.А., Myrzabayeva A.Н., Ilin A.I. Isolation and characterization isolates of nosocomial infections // Bulletin of National Academy of Sciences of the Republic of Kazakhstan. – 2019. – Vol. 5, No. 381. – P. 199-209. Crossref.